
Masoud H. Noori
Examiner (ID: 3784, Phone: (571)272-2185 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2855, 2214, 2856, 2616 |
| Total Applications | 3955 |
| Issued Applications | 3448 |
| Pending Applications | 170 |
| Abandoned Applications | 350 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16642424
[patent_doc_number] => 10920265
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Compounds and methods for detection of enzymes that remove methyl succinyl groups from epsilon-amino lysine moieties
[patent_app_type] => utility
[patent_app_number] => 16/833816
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16041
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 339
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16833816
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/833816 | Compounds and methods for detection of enzymes that remove methyl succinyl groups from epsilon-amino lysine moieties | Mar 29, 2020 | Issued |
Array
(
[id] => 18341236
[patent_doc_number] => 11638705
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => 4(1H)-quinolone derivatives and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/831346
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 48
[patent_no_of_words] => 38092
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 436
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16831346
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/831346 | 4(1H)-quinolone derivatives and uses thereof | Mar 25, 2020 | Issued |
Array
(
[id] => 18717823
[patent_doc_number] => 11795154
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Method for the synthesis of 2,5-furandicarboxylic acid
[patent_app_type] => utility
[patent_app_number] => 17/440360
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4760
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/440360 | Method for the synthesis of 2,5-furandicarboxylic acid | Mar 19, 2020 | Issued |
Array
(
[id] => 17641902
[patent_doc_number] => 20220169640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => PRODUCTION METHOD OF QUINOLINECARBOXAMIDE DERIVATIVE OR PRODUCTION INTERMEDIATE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/441978
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/441978 | PRODUCTION METHOD OF QUINOLINECARBOXAMIDE DERIVATIVE OR PRODUCTION INTERMEDIATE THEREOF | Mar 18, 2020 | Abandoned |
Array
(
[id] => 17611448
[patent_doc_number] => 20220153727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => METHOD FOR PRODUCING PYRROLE-IMIDAZOLE (POLY)AMIDE
[patent_app_type] => utility
[patent_app_number] => 17/442306
[patent_app_country] => US
[patent_app_date] => 2020-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17442306
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/442306 | Method for producing pyrrole-imidazole (poly)amide | Mar 11, 2020 | Issued |
Array
(
[id] => 16877932
[patent_doc_number] => 11028065
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-06-08
[patent_title] => Continuous method for preparing carbonate esters
[patent_app_type] => utility
[patent_app_number] => 16/812628
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 8441
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 275
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16812628
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/812628 | Continuous method for preparing carbonate esters | Mar 8, 2020 | Issued |
Array
(
[id] => 19884138
[patent_doc_number] => 12269830
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Process for preparation of tofacitinib and pharmaceutically acceptable salt thereof
[patent_app_type] => utility
[patent_app_number] => 17/435605
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1575
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435605
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/435605 | Process for preparation of tofacitinib and pharmaceutically acceptable salt thereof | Mar 3, 2020 | Issued |
Array
(
[id] => 17603974
[patent_doc_number] => 11332445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission
[patent_app_type] => utility
[patent_app_number] => 16/801354
[patent_app_country] => US
[patent_app_date] => 2020-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12066
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16801354
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/801354 | Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission | Feb 25, 2020 | Issued |
Array
(
[id] => 19594195
[patent_doc_number] => 12152025
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-26
[patent_title] => Process for preparing alkynyl-containing compound and intermediate thereof
[patent_app_type] => utility
[patent_app_number] => 17/264762
[patent_app_country] => US
[patent_app_date] => 2020-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8314
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264762
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264762 | Process for preparing alkynyl-containing compound and intermediate thereof | Feb 25, 2020 | Issued |
Array
(
[id] => 16769729
[patent_doc_number] => 10980812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => 3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
[patent_app_type] => utility
[patent_app_number] => 16/801000
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 19985
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16801000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/801000 | 3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus | Feb 24, 2020 | Issued |
Array
(
[id] => 16052983
[patent_doc_number] => 20200188346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => METHOD OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/800611
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16800611
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/800611 | Method of treatment | Feb 24, 2020 | Issued |
Array
(
[id] => 16533252
[patent_doc_number] => 10875835
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Method for producing 2-acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dione
[patent_app_type] => utility
[patent_app_number] => 16/798833
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7960
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798833
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/798833 | Method for producing 2-acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dione | Feb 23, 2020 | Issued |
Array
(
[id] => 19763148
[patent_doc_number] => 12221421
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Process for synthesis of Fipronil
[patent_app_type] => utility
[patent_app_number] => 17/439870
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4238
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439870
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/439870 | Process for synthesis of Fipronil | Feb 23, 2020 | Issued |
Array
(
[id] => 17251090
[patent_doc_number] => 11186562
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-30
[patent_title] => Quinolin-2-one derivatives
[patent_app_type] => utility
[patent_app_number] => 16/795972
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38814
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 392
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795972
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795972 | Quinolin-2-one derivatives | Feb 19, 2020 | Issued |
Array
(
[id] => 17221751
[patent_doc_number] => 11174241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Quinolin-2-one derivatives
[patent_app_type] => utility
[patent_app_number] => 16/796046
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39295
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 342
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16796046
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/796046 | Quinolin-2-one derivatives | Feb 19, 2020 | Issued |
Array
(
[id] => 17281681
[patent_doc_number] => 11198701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Biaryl ligands, methods of making biarlyl ligands, and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/792794
[patent_app_country] => US
[patent_app_date] => 2020-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 41
[patent_no_of_words] => 17742
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16792794
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/792794 | Biaryl ligands, methods of making biarlyl ligands, and methods of use thereof | Feb 16, 2020 | Issued |
Array
(
[id] => 18309720
[patent_doc_number] => 20230113620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => USE OF JAK INHIBITORS IN PREPARATION OF DRUGS FOR TREATING JAK KINASE-RELATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/760233
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760233
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760233 | Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases | Feb 12, 2020 | Issued |
Array
(
[id] => 17563118
[patent_doc_number] => 20220127267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => THIENO[3,2-B] PYRROLE[3,2-D]PYRIDAZINONE DERIVATIVES AND THEIR USE AS PKM2 DERIVATIVES FOR THE TREATMENT OF CANCER, OBESITY AND DIABETES RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/429073
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 482
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429073
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/429073 | THIENO[3,2-B] PYRROLE[3,2-D]PYRIDAZINONE DERIVATIVES AND THEIR USE AS PKM2 DERIVATIVES FOR THE TREATMENT OF CANCER, OBESITY AND DIABETES RELATED DISORDERS | Feb 11, 2020 | Abandoned |
Array
(
[id] => 17938360
[patent_doc_number] => 11472801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Crystalline forms of a FGFR inhibitor and processes for preparing the same
[patent_app_type] => utility
[patent_app_number] => 16/783839
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 27865
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16783839
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/783839 | Crystalline forms of a FGFR inhibitor and processes for preparing the same | Feb 5, 2020 | Issued |
Array
(
[id] => 16483883
[patent_doc_number] => 20200377484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => SOLID FORMS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL) BENZOIC ACID
[patent_app_type] => utility
[patent_app_number] => 16/783338
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16783338
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/783338 | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid | Feb 5, 2020 | Issued |